Compare Aurora Cannabis Inc (ACB) vs Rigetti Computing Inc (RGTI) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Rigetti Computing (RGTI) trades at $17.96, near recent support levels, with a bearish technical outlook despite recent quarterly earnings beats. The company shows severe financial strain with a net income margin of -2,253.59% and negative cash flow from operations, though it maintains a strong cash position of $569 million. Recent news highlights expansion in quantum computing access and government contracts, but the sector faces long commercialization timelines.

The stock presents a high-risk, speculative opportunity with significant analyst optimism (85.71% buy rating) and a consensus price target of $32.67, implying substantial upside. However, investors face risks from cash burn, lack of profitability, and the nascent stage of quantum computing commercialization, requiring careful consideration of the long-term horizon and execution capabilities.